Harvard Bioscience Inc (HBIO) stock
HBIONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 3/3040% above fair value
$9.08+0.17 (+1.91%)
Close on Nov 17, 2026Market cap $41.33MP/E –Yield –
Harvard Bioscience total assets
Total assets on the balance sheet at the end of each period.
Harvard Bioscience's total assets was $76.29M at Jun 30, 2026. For fiscal 2025 it was $80.07M, down 36.8% from the year before. Over ten years it grew -4.0% a year on average. The highest annual figure on record is $168.61M in fiscal 2018.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $80.07M | -36.8% |
| FY2024 | Dec 31, 2024 | $126.64M | -7.8% |
| FY2023 | Dec 31, 2023 | $137.37M | -5.5% |
| FY2022 | Dec 31, 2022 | $145.36M | -10.5% |
| FY2021 | Dec 31, 2021 | $162.34M | +3.9% |
| FY2020 | Dec 31, 2020 | $156.25M | -5.2% |
| FY2019 | Dec 31, 2019 | $164.87M | -2.2% |
| FY2018 | Dec 31, 2018 | $168.61M | +54.2% |
| FY2017 | Dec 31, 2017 | $109.35M | +1.5% |
| FY2016 | Dec 31, 2016 | $107.77M | -10.2% |
| FY2015 | Dec 31, 2015 | $120.05M | -11.7% |
| FY2014 | Dec 31, 2014 | $135.92M | +0.3% |
| FY2013 | Dec 31, 2013 | $135.46M | +1.5% |
| FY2012 | Dec 31, 2012 | $133.48M | +5.4% |
| FY2011 | Dec 31, 2011 | $126.63M | +1.5% |
| FY2010 | Dec 31, 2010 | $124.80M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $76.29M | -4.8% |
| Q1 FY2026 | Mar 31, 2026 | $77.94M | -2.3% |
| Q4 FY2025 | Dec 31, 2025 | $80.07M | -36.8% |
| Q3 FY2025 | Sep 30, 2025 | $77.99M | -40.6% |
| Q2 FY2025 | Jun 30, 2025 | $80.09M | -37.9% |
| Q1 FY2025 | Mar 31, 2025 | $79.80M | -40.1% |
| Q4 FY2024 | Dec 31, 2024 | $126.64M | -7.8% |
| Q3 FY2024 | Sep 30, 2024 | $131.24M | -6.1% |
| Q2 FY2024 | Jun 30, 2024 | $128.91M | -9.8% |
| Q1 FY2024 | Mar 31, 2024 | $133.16M | -8.5% |
| Q4 FY2023 | Dec 31, 2023 | $137.37M | -5.5% |
| Q3 FY2023 | Sep 30, 2023 | $139.74M | -5.0% |
| Q2 FY2023 | Jun 30, 2023 | $142.90M | -8.0% |
| Q1 FY2023 | Mar 31, 2023 | $145.58M | -7.9% |
| Q4 FY2022 | Dec 31, 2022 | $145.36M | -10.5% |
| Q3 FY2022 | Sep 30, 2022 | $147.01M | -4.5% |
| Q2 FY2022 | Jun 30, 2022 | $155.27M | +0.8% |
| Q1 FY2022 | Mar 31, 2022 | $158.04M | +4.5% |
| Q4 FY2021 | Dec 31, 2021 | $162.34M | +3.9% |
| Q3 FY2021 | Sep 30, 2021 | $153.87M | +2.8% |
| Q2 FY2021 | Jun 30, 2021 | $153.97M | +2.2% |
| Q1 FY2021 | Mar 31, 2021 | $151.25M | -3.2% |
| Q4 FY2020 | Dec 31, 2020 | $156.25M | -5.2% |
| Q3 FY2020 | Sep 30, 2020 | $149.61M | -8.1% |
| Q2 FY2020 | Jun 30, 2020 | $150.69M | -9.4% |
| Q1 FY2020 | Mar 31, 2020 | $156.26M | -8.8% |
| Q4 FY2019 | Dec 31, 2019 | $164.87M | -2.2% |
| Q3 FY2019 | Sep 30, 2019 | $162.78M | -1.4% |
| Q2 FY2019 | Jun 30, 2019 | $166.24M | +0.7% |
| Q1 FY2019 | Mar 31, 2019 | $171.34M | +0.2% |
| Q4 FY2018 | Dec 31, 2018 | $168.61M | +54.2% |
| Q3 FY2018 | Sep 30, 2018 | $165.04M | +49.1% |
| Q2 FY2018 | Jun 30, 2018 | $165.05M | +51.6% |
| Q1 FY2018 | Mar 31, 2018 | $170.95M | +59.2% |
| Q4 FY2017 | Dec 31, 2017 | $109.35M | +1.5% |
| Q3 FY2017 | Sep 30, 2017 | $110.68M | -1.3% |
| Q2 FY2017 | Jun 30, 2017 | $108.86M | – |
| Q1 FY2017 | Mar 31, 2017 | $107.40M | – |
| Q4 FY2016 | Dec 31, 2016 | $107.77M | – |
| Q3 FY2016 | Sep 30, 2016 | $112.18M | – |
See a number that looks wrong?